Table 1 Est. Pt. No. Age & sex 1979 thyroid dose (rads) (cont'd) Thyroid Nodularities Age at detection Surgery Hypofunction Diagnosis TSH (uU/d1) (c) Rongelap exposed at age >18 18 F 64 F 45 55 335 335 78 F 62 335 34 F 70 335 4M 63 71 F 52 66 F 55 335 34 41 Cleve. '69 Bost. '65 Papillary Ca Papillary Ca 6.0, 335 335 7.0 6.6, 8.8 6.5, 7.0 55 Cleve. '79 Adenomatous nod. Cleve. '72 Adenomatous nod. 6.3, 8.3 (d) Ailingnae exposed at age <10 8 F 53 F — 26 33 450 320 18 28 Cleve. (e) Ailingnae exposed at age 10-18: ‘81 Occult Pap. Ca and adenomatous nod. NONE (f) Ailingnae exposed at age >18 51 F 50 45 F 57 41 M 135 135 59 F 69 -- 135 16 M 64 135 135 45 Cleve. 51 Cleve. 53 Bost. ‘74 '73 '66 Adenoma Adenomatous nod. Nodule Adenomatous nod. (died '68, age 54) 6.4, 6.5 (g) Utirik exposed at age <10 2160 F 2154 F 3] 29 80 75 28 25 Cleve. '75 2147 F 26 90 25 Cleve. '79 2239 F 2132 F 28 27 80 80 28 27 Cleve. '81 Cleve. '81 Cleve. '76 Papillary Ca Nodule reduced '79 Adenomatous nod. " " " " (h) Utirik exposed at age 10-18 2229 F 2150 M 43 37 54 31 32 33 Cleve. 2236 M 36 55 34 Hono. '69 '78 - 126 - Adenoma Papillary Ca vs. atypical adenoma Adenoma